Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Brandy D. McGinnis, PharmD
Advertisement
Articles by Brandy D. McGinnis, PharmD
Advertisement
Latest Updated Articles
- Statin Adherence and Mortality in Patients Enrolled in a Secondary Prevention Program
Published: October 8th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Team-Based Precision Oncology: Advancing Value and Access in Cancer Care
2
Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care
3
From HIV Treatment Switching to Disease Prevention
4
Meeting the Needs of Patients With HIV: Virologic Suppression and the Expanding Treatment Landscape
5
